News about Opexa

A board to discuss Tcelna as a treatment for Multiple Sclerosis

Postby Lyon » Tue Dec 04, 2007 9:03 pm

.
Last edited by Lyon on Thu Dec 01, 2011 5:33 pm, edited 1 time in total.
Lyon
Family Elder
 
Posts: 6063
Joined: Wed May 03, 2006 2:00 pm

Advertisement

Postby Lyon » Thu Dec 13, 2007 2:01 pm

.
Last edited by Lyon on Wed Nov 30, 2011 6:54 pm, edited 1 time in total.
Lyon
Family Elder
 
Posts: 6063
Joined: Wed May 03, 2006 2:00 pm

Postby toasterpastery » Sun Dec 16, 2007 12:59 pm

I suspect Opexa's stock price is getting crushed because they are about to do another round of fundraising. This happened the last time they sold shares. I would guess that they will try to raise another $20 million. This is going to be highly dilutive. It might double the number of shares outstanding. The stock is being crushed in anticipation. If you are considering buying then you just wait until the offering and buy afterwards. They will run out of money in the first half of next year so I suspect we will see something happen in Feb or March. The stock could jump a few bucks after the offering. If I remember correctly that's what happened last time.

Just my thoughts on the matter.
User avatar
toasterpastery
Newbie
 
Posts: 4
Joined: Sat Dec 15, 2007 3:00 pm

Opexa... does it have the resources?

Postby toasterpastery » Fri Feb 22, 2008 7:06 am

This is interesting. It looks like Opexa just sold more stock to fund their operations. However, They only raised about 8 or $9m. This seems to be abount enough to take them through the end of Phase IIb but no further. Their stock price is now in the toilet. I am deepl concerned that they will have not enough money to pay for a phase III. A phase III might cost over $100M. I wonder if they will need to get bought or partner with someone else. This will all require great results from Phase IIb.

Chime in if anyone has any thoughts or shares similar concerns.
User avatar
toasterpastery
Newbie
 
Posts: 4
Joined: Sat Dec 15, 2007 3:00 pm

Postby schnittke » Fri Feb 22, 2008 8:05 am

Just to echo your concerns I can't imagine how OPEXA wil mangage to fund a 100M phase III trial when they are struggling to raise 8M or so to complete the phase IIb. .Obviously this an overly simplistic summary but it does seem worrisome for such a hopeful drug. Looks to me that either they have to raise major cash in nine months or they sell it.
User avatar
schnittke
Family Member
 
Posts: 27
Joined: Sun Jan 06, 2008 3:00 pm

Postby Lyon » Fri Feb 22, 2008 9:05 am

.
Last edited by Lyon on Tue Nov 29, 2011 6:06 pm, edited 1 time in total.
Lyon
Family Elder
 
Posts: 6063
Joined: Wed May 03, 2006 2:00 pm

more financial info

Postby toasterpastery » Fri Feb 22, 2008 9:07 am

Actually I did some additional looking into Opexa's financials since the time of my last post and it's worse that I thought. They raised only about $6m in cash and they burn about $1m a month. Considering they had about a million or two in cash before raising the funds, this gives them about enough to get to the start of the 4th quarter.

They said that results of Phase 2b would be released in the 4th quarter. So this means that they need to raise money again just to produce phase 2b results. It's looking touch and go here. Not very reassuring.

You're correct that it seems unlikely that investors will pony up $100m+ to take this drug through Phase 3.

Again, should be interesting.
User avatar
toasterpastery
Newbie
 
Posts: 4
Joined: Sat Dec 15, 2007 3:00 pm

Previous

Return to Tcelna (Tovaxin)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service